Nakamura Mariko, Nose-Ogura Sayaka
Department of Sports Sciences, Japan Institute of Sports Sciences, Tokyo, Japan.
Department of Sports Medical Center, Japan Institute of Sports Sciences, Tokyo, Japan.
J Obstet Gynaecol Res. 2021 Feb;47(2):792-799. doi: 10.1111/jog.14613. Epub 2020 Dec 17.
To examine the effects of administration of monophasic oral contraceptive (OC) on the body composition and aerobic and anaerobic capacities of female athletes.
Ten female athletes (23.0 ± 4.1 years old) participated in this study. All the subjects were examined during the menstrual cycle (early follicular [EF], middle luteal [ML]) and OC cycle (inactive OC, and active OC phases). After the menstrual cycle measurements, all the subjects began taking OC. The athletes tested using a body composition, circumferences, the lactate curve test, the maximal oxygen consumption test, and the Wingate test during all phases.
Waist circumference was lower during the OC cycle than menstrual cycle (P < 0.05), and the other circumferences of parts were not different during the menstrual or OC cycles. However, there were no differences in body composition before and after taking OC. The phase of the menstrual or OC cycle did not affect maximal oxygen consumption, heart rate max or power output at a blood lactate concentration of 2 and 4 mmol/L between the menstrual and OC cycle phases. Although, the peak blood lactate level after the Wingate test was higher during the OC cycle (inactive OC phase, 13.0 ± 2.4 mmol/L; active OC phase, 12.4 ± 3.0 mmol/L) than during the menstrual cycle (EF phase, 11.9 ± 2.1 mmol/L; ML phase, 11.4 ± 2.1 mmol/L; P < 0.05), the peak and average power in the Wingate test did not change during the menstrual and OC cycle phases.
Administration of monophasic OC did not affect the body composition or aerobic and anaerobic capacities of female athletes.
探讨单相口服避孕药(OC)对女运动员身体成分以及有氧和无氧运动能力的影响。
10名女运动员(23.0±4.1岁)参与了本研究。所有受试者在月经周期(卵泡早期[EF]、黄体中期[ML])和OC周期(OC非活性期、OC活性期)接受检查。在月经周期测量后,所有受试者开始服用OC。运动员在所有阶段均接受身体成分、周长、乳酸曲线测试、最大耗氧量测试和温盖特测试。
OC周期的腰围低于月经周期(P<0.05),月经周期和OC周期各部位的其他周长无差异。然而,服用OC前后身体成分无差异。月经周期或OC周期阶段对月经周期和OC周期阶段之间的最大耗氧量、心率最大值或血乳酸浓度为2和4 mmol/L时的功率输出无影响。尽管温盖特测试后的血乳酸峰值水平在OC周期(OC非活性期,13.0±2.4 mmol/L;OC活性期,12.4±3.0 mmol/L)高于月经周期(EF期,11.9±2.1 mmol/L;ML期,11.4±2.1 mmol/L;P<0.05),但温盖特测试中的峰值功率和平均功率在月经周期和OC周期阶段未发生变化。
单相OC的使用对女运动员的身体成分以及有氧和无氧运动能力没有影响。